{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:31:37Z","timestamp":1789637497126,"version":"4.0.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T00:00:00Z","timestamp":1484352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Novaliq GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s00417-016-3572-y","type":"journal-article","created":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T01:00:51Z","timestamp":1484355651000},"page":"767-775","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A semifluorinated alkane (F4H5) as novel carrier for cyclosporine A: a promising therapeutic and prophylactic option for topical treatment of dry eye"],"prefix":"10.1007","volume":"255","author":[{"given":"Uta","family":"Gehlsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Notara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Kr\u00f6sser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,14]]},"reference":[{"issue":"1","key":"3572_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3109\/08830185.2012.748052","volume":"32","author":"ME Stern","year":"2013","unstructured":"Stern ME, Schaumburg CS, Pflugfelder SC (2013) Dry eye as a mucosal autoimmune disease. Int Rev Immunol 32(1):19\u201341. doi: 10.3109\/08830185.2012.748052","journal-title":"Int Rev Immunol"},{"issue":"3","key":"3572_CR2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.exer.2003.09.003","volume":"78","author":"ME Stern","year":"2004","unstructured":"Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC (2004) The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res 78(3):409\u2013416","journal-title":"Exp Eye Res"},{"key":"3572_CR3","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1016\/S0039-6257(00)00205-8","volume":"45","author":"M Calonge","year":"2001","unstructured":"Calonge M (2001) The treatment of dry eye. Surv Ophthalmol 45:S227\u2013S239. doi: 10.1016\/S0039-6257(00)00205-8","journal-title":"Surv Ophthalmol"},{"issue":"5","key":"3572_CR4","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1055\/s-0031-1299519","volume":"229","author":"P Steven","year":"2012","unstructured":"Steven P, Cursiefen C (2012) Anti-inflammatory treatment in dry eye disease. Klin Monatsbl Augenheilkd 229(5):500\u2013505. doi: 10.1055\/s-0031-1299519","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"1","key":"3572_CR5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","volume":"24","author":"B Strong","year":"2005","unstructured":"Strong B, Farley W, Stern ME, Pflugfelder SC (2005) Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca. Cornea 24(1):80\u201385","journal-title":"Cornea"},{"issue":"4","key":"3572_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0161-6420(99)00176-1","volume":"107","author":"K Sall","year":"2000","unstructured":"Sall K, Stevenson OD, Mundorf TK, Reis BL, Grp CPS (2000) Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology 107(4):631\u2013639. doi: 10.1016\/S0161-6420(99)00176-1","journal-title":"Ophthalmology"},{"issue":"3","key":"3572_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.survophthal.2009.02.002","volume":"54","author":"E Donnenfeld","year":"2009","unstructured":"Donnenfeld E, Pflugfelder SC (2009) Topical ophthalmic cyclosporine: pharmacology and clinical uses. Surv Ophthalmol 54(3):321\u2013338. doi: 10.1016\/j.survophthal.2009.02.002","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"3572_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1089\/jop.2010.0085","volume":"27","author":"JD Sheppard","year":"2011","unstructured":"Sheppard JD, Scoper SV, Samudre S (2011) Topical loteprednol pretreatment reduces cyclosporine stinging in chronic dry eye disease. J Ocul Pharmacol Ther 27(1):23\u201327. doi: 10.1089\/jop.2010.0085","journal-title":"J Ocul Pharmacol Ther"},{"issue":"2","key":"3572_CR9","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cis.2007.11.002","volume":"138","author":"M Broniatowski","year":"2008","unstructured":"Broniatowski M, Dynarowicz-Latka P (2008) Semifluorinated alkanes\u2014primitive surfactants of fascinating properties. Adv Colloid Interf Sci 138(2):63\u201383. doi: 10.1016\/j.cis.2007.11.002","journal-title":"Adv Colloid Interf Sci"},{"issue":"3","key":"3572_CR10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/112067210001000301","volume":"10","author":"H Meinert","year":"2000","unstructured":"Meinert H (2000) Semifluorinated alkanes. Eur J Ophthalmol 10(3):189\u2013197","journal-title":"Eur J Ophthalmol"},{"key":"3572_CR11","doi-asserted-by":"publisher","unstructured":"Dutescu RM, Panfil C, Merkel OM, Schrage N (2014) Semifluorinated alkanes as a liquid drug carrier system for topical ocular drug delivery. Eur J Pharm Biopharm 88(1):123--128. doi: 10.1016\/j.ejpb.2014.05.009","DOI":"10.1016\/j.ejpb.2014.05.009"},{"issue":"5","key":"3572_CR12","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1055\/s-0035-1545830","volume":"232","author":"S Siebelmann","year":"2015","unstructured":"Siebelmann S, Jing B, Cursiefen C, Steven P (2015) Non-invasive diagnosis of ocular graft-versus-host disease. Klin Monatsbl Augenheilkd 232(5):652\u2013657. doi: 10.1055\/s-0035-1545830","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"3","key":"3572_CR13","first-page":"632","volume":"43","author":"D Dursun","year":"2002","unstructured":"Dursun D, Wang M, Monroy D, Li DQ, Lokeshwar BL, Stern ME, Pflugfelder SC (2002) A mouse model of keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci 43(3):632\u2013638","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3572_CR14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00003226-200310000-00008","volume":"22","author":"AJ Bron","year":"2003","unstructured":"Bron AJ, Evans VE, Smith JA (2003) Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea 22(7):640\u2013650","journal-title":"Cornea"},{"issue":"5","key":"3572_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s10792-014-9901-4","volume":"34","author":"H Deveci","year":"2014","unstructured":"Deveci H, Kobak S (2014) The efficacy of topical 0.05% cyclosporine A in patients with dry eye disease associated with Sjogren\u2019s syndrome. Int Ophthalmol 34(5):1043\u20131048. doi: 10.1007\/s10792-014-9901-4","journal-title":"Int Ophthalmol"},{"issue":"5","key":"3572_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ICL.0000000000000049","volume":"40","author":"JD Sheppard","year":"2014","unstructured":"Sheppard JD, Donnenfeld ED, Holland EJ, Slonim CB, Solomon R, Solomon KD, McDonald MB, Perry HD, Lane SS, Pflugfelder SC, Samudre SS (2014) Effect of loteprednol etabonate 0.5% on initiation of dry eye treatment with topical cyclosporine 0.05%. Eye Contact Lens 40(5):289\u2013296. doi: 10.1097\/ICL.0000000000000049","journal-title":"Eye Contact Lens"},{"issue":"3","key":"3572_CR17","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S1081-1206(10)61958-8","volume":"89","author":"N Pucci","year":"2002","unstructured":"Pucci N, Novembre E, Cianferoni A, Lombardi E, Bernardini R, Caputo R, Campa L, Vierucci A (2002) Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis. Ann Allergy Asthma Immunol 89(3):298\u2013303. doi: 10.1016\/S1081-1206(10)61958-8","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"3572_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/Mi.2013.20","volume":"7","author":"Y Chen","year":"2014","unstructured":"Chen Y, Chauhan SK, Lee HS, Saban DR, Dana R (2014) Chronic dry eye disease is principally mediated by effector memory Th17 cells. Mucosal Immunol 7(1):38\u201345. doi: 10.1038\/Mi.2013.20","journal-title":"Mucosal Immunol"},{"issue":"10","key":"3572_CR19","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1167\/Iovs.11-7231","volume":"52","author":"KC Yoon","year":"2011","unstructured":"Yoon KC, Ahn KY, Choi W, Li Z, Choi JS, Lee SH, Park SH (2011) Tear production and ocular surface changes in experimental dry eye after elimination of desiccating stress. Invest Ophthalmol Vis Sci 52(10):7267\u20137273. doi: 10.1167\/Iovs.11-7231","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"3572_CR20","doi-asserted-by":"crossref","first-page":"3950","DOI":"10.4049\/jimmunol.176.7.3950","volume":"176","author":"JY Niederkorn","year":"2006","unstructured":"Niederkorn JY, Stern ME, Pflugfelder SC, De Paiva CS, Corrales RM, Gao J, Siemasko K (2006) Desiccating stress induces T cell-mediated Sjogren\u2019s Syndrome-like lacrimal keratoconjunctivitis. J Immunol 176(7):3950\u20133957","journal-title":"J Immunol"},{"issue":"8","key":"3572_CR21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.120.3.330","volume":"120","author":"KS Kunert","year":"2002","unstructured":"Kunert KS, Tisdale AS, Gipson IK (2002) Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol 120(8):330\u2013337","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"3572_CR22","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.4049\/jimmunol.1101442","volume":"187","author":"CS Schaumburg","year":"2011","unstructured":"Schaumburg CS, Siemasko KF, De Paiva CS, Wheeler LA, Niederkorn JY, Pflugfelder SC, Stern ME (2011) Ocular surface APCs are necessary for autoreactive T cell-mediated experimental autoimmune lacrimal keratoconjunctivitis. J Immunol 187(7):3653\u20133662. doi: 10.4049\/jimmunol.1101442","journal-title":"J Immunol"},{"issue":"8","key":"3572_CR23","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1167\/iovs.08-2417","volume":"50","author":"J Annan El","year":"2009","unstructured":"El Annan J, Chauhan SK, Ecoiffier T, Zhang Q, Saban DR, Dana R (2009) Characterization of effector T cells in dry eye disease. Invest Ophthalmol Vis Sci 50(8):3802\u20133807. doi: 10.1167\/iovs.08-2417","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"3572_CR24","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1167\/iovs.08-2075","volume":"49","author":"KF Siemasko","year":"2008","unstructured":"Siemasko KF, Gao J, Calder VL, Hanna R, Calonge M, Pflugfelder SC, Niederkorn JY, Stern ME (2008) In vitro expanded CD4+CD25+Foxp3+ regulatory T cells maintain a normal phenotype and suppress immune-mediated ocular surface inflammation. Invest Ophthalmol Vis Sci 49(12):5434\u20135440. doi: 10.1167\/iovs.08-2075","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3572_CR25","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1189\/Jlb.0604341","volume":"78","author":"X Chen","year":"2005","unstructured":"Chen X, Oppenheim JJ, Howard OMZ (2005) BALB\/c mice have more CD4(+)CD25(+) T regulatory cells and show greater susceptibility to suppression of their CD4(+)CD25(-) responder T cells than C57BL\/6 mice. J Leukoc Biol 78(1):114\u2013121. doi: 10.1189\/Jlb.0604341","journal-title":"J Leukoc Biol"},{"issue":"9","key":"3572_CR26","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1167\/iovs.14-16307","volume":"56","author":"MJ Lee","year":"2015","unstructured":"Lee MJ, Kim DH, Ryu JS, Ko AY, Ko JH, Kim MK, Wee WR, Khwarg SI, Oh JY (2015) Topical TSG-6 administration protects the ocular surface in two mouse models of inflammation-related dry eye. Invest Ophthalmol Vis Sci 56(9):5175\u20135181. doi: 10.1167\/iovs.14-16307","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3572_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/jop.2010.0019","volume":"26","author":"N Li","year":"2010","unstructured":"Li N, He J, Schwartz CE, Gjorstrup P, Bazan HE (2010) Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model. J Ocul Pharmacol Ther 26(5):431\u2013439. doi: 10.1089\/jop.2010.0019","journal-title":"J Ocul Pharmacol Ther"},{"issue":"5","key":"3572_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/ICL.0b013e318184bdb6","volume":"34","author":"AK Nyunt","year":"2008","unstructured":"Nyunt AK, Ishida Y, Yu Y, Shimada S (2008) Topical apolipoprotein A-1 may have a beneficial effect on the corneal epithelium in a mouse model of dry eye: a pilot study. Eye Contact Lens 34(5):287\u2013292. doi: 10.1097\/ICL.0b013e318184bdb6","journal-title":"Eye Contact Lens"},{"issue":"4","key":"3572_CR29","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1167\/iovs.12-11121","volume":"54","author":"Y Chen","year":"2013","unstructured":"Chen Y, Chauhan SK, Lee HS, Stevenson W, Schaumburg CS, Sadrai Z, Saban DR, Kodati S, Stern ME, Dana R (2013) Effect of desiccating environmental stress versus systemic muscarinic AChR blockade on dry eye immunopathogenesis. Invest Ophthalmol Vis Sci 54(4):2457\u20132464. doi: 10.1167\/iovs.12-11121","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"3572_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/mi.2009.5","volume":"2","author":"CS Paiva De","year":"2009","unstructured":"De Paiva CS, Chotikavanich S, Pangelinan SB, Pitcher JD 3rd, Fang B, Zheng X, Ma P, Farley WJ, Siemasko KF, Niederkorn JY, Stern ME, Li DQ, Pflugfelder SC (2009) IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol 2(3):243\u2013253. doi: 10.1038\/mi.2009.5","journal-title":"Mucosal Immunol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-016-3572-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-016-3572-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:09:39Z","timestamp":1568718579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-016-3572-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,14]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["3572"],"URL":"https:\/\/doi.org\/10.1007\/s00417-016-3572-y","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,14]]}}}